Free Trial

Orchestra BioMed (OBIO) Insider Trading & Ownership

Orchestra BioMed logo
$5.39 +0.11 (+2.08%)
(As of 01:20 PM ET)

Orchestra BioMed (NASDAQ:OBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.70%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$61,825.00
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$138,572.97
Get OBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

OBIO Insider Buying and Selling by Quarter

Orchestra BioMed Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/24/2024David P HochmanInsiderBuy2,500$4.91$12,275.00  
9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92  
9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.00  
9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35  
9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.00  
9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70  
8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00  
6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00  
5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00  
(Data available from 1/1/2013 forward)

OBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Orchestra BioMed includes Darren Sherman, David P Hochman, Eric S Fain, and William Reed Little. Learn more on insiders at OBIO.

6.70% of Orchestra BioMed stock is owned by insiders. Learn more on OBIO's insider holdings.

The following insiders have purchased OBIO shares in the last 24 months: David P Hochman ($33,825.00), and William Reed Little ($28,000.00).

Insiders have purchased a total of 10,000 OBIO shares in the last 24 months for a total of $61,825.00 bought.

The following insiders have sold OBIO shares in the last 24 months: Darren Sherman ($117,518.97), and Eric S Fain ($21,054.00).

Insiders have sold a total of 24,260 Orchestra BioMed shares in the last 24 months for a total of $138,572.97 sold.

Orchestra BioMed Key Executives

  • Mr. David P. Hochman (Age 49)
    Founder, Chairman of the Board of Directors & CEO
    Compensation: $942k
    3 recent trades
  • Mr. Darren R. Sherman (Age 53)
    Founder, President, COO & Director
    Compensation: $787k
    3 recent trades
  • Mr. Andrew Lawrence Taylor M.B.A. (Age 53)
    Chief Financial Officer
    Compensation: $500.02k
  • Mr. William Reed Little (Age 53)
    Executive Vice President of Corporate Development & Strategy
    1 recent trades
  • Dr. Yuval Hay Mika D.Sc (Age 65)
    Ph.D., GM & CTO of Bioelectronic Therapies
  • Dr. George Papandreou Ph.D. (Age 59)
    GM & Senior VP of Focal Therapies
  • Dr. Hans-Peter Stoll M.D.
    Ph.D., Chief Clinical Officer
  • Dr. Avraham Matityahu Fischer M.D. (Age 68)
    Senior Vice President of Medical Affairs & Innovation
  • Mr. Bob Laughner
    Senior Vice President of Regulatory & Quality
  • Mr. Juan Lorenzo
    Senior Vice President of Product Development


This page (NASDAQ:OBIO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners